News & Events


See the BD Calendar of Events


7 July, 2010
Launch of BD BACTEC™ MGIT™ 320 System Expands TB Detection Worldwide

23 June, 2010
BD Announces European Launch of the BD MAX™ System for Molecular Diagnostics

29 March, 2010
ECCMID 2010 - Come and visit us at the BD booth no. 561

8 February, 2010
BD Expands Diagnostic Testing Offerings in Women's Health

8 January, 2010
Wishing for the easiest solution: from specimen collection to a rapid diagnosis…

7 January, 2010
Help women prevent Cervical Cancer

20 November, 2009
BD Completes Acquisition of HandyLab, Inc.

30 October, 2009
Make the BD FocalPoint™ GS Imaging System your guide in cervical cytology screening.

30 October, 2009
Your Global Partner for Industrial Excellence

23 October, 2009
BD Announces Agreement to Acquire HandyLab, Inc.

1 October, 2009
Maximizing Productivity with BD Phoenix™ AP »

1 October, 2009
Launch of BD MGIT™ TBc Identification Test in Africa and the European Union »

1 October, 2009
Reliable detection, identification and screening with BD BBL™ CHROMagar™ Products.»

28 September, 2009
BD Receives Health Canada Approval for the BD FocalPoint™ GS Imaging System to Enhance the Detection of Cervical Cancer

12 September, 2009
Introducing the BD FocalPoint™ GS Imaging System

6 August, 2009
BD Adds Surveillance Capability to Infectious Disease Portfolio »

18 May, 2009
BD and HandyLab Announce Exclusive Collaboration to Commercialize Molecular Assays »

4 May, 2009
BD and Fujirebio Diagnostics Sign Worldwide Agreement to Develop Biomarker Assays to Improve Cancer Detection and Management

26 February, 2009
New BD BACTEC™ FX Blood Culture System with the BD EpiCenter™ Microbiology Data Management System now Available Worldwide

7 July, 2008
BD GeneOhm™ Cdiff Assay CE Marked and Submitted for FDA Clearance

2 June, 2008
New BD BACTEC™ FX Blood Culture Instrument with the BD EpiCenter™ Operating System can Facilitate Fast and Effective Clinical Decisions for Patients with Bacterial Infections

17 March, 2008
BD GeneOhm™ MRSA Assay Part of Largest U.S. Study Using Universal Active Surveillance to Significantly Reduce MRSA Infection Rates


Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2015 BD